Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care
about
Tissue biomarkers of breast cancer and their association with conventional pathologic features.The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidenceUnderutilization of gene expression profiling for early-stage breast cancer in California21-gene recurrence assay in patients receiving intraoperative radiotherapy: are “favorable” characteristics a surrogate for low recurrence?Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy.
P2860
Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Gene expression profile testin ...... rse effects, and costs of care
@ast
Gene expression profile testin ...... rse effects, and costs of care
@en
type
label
Gene expression profile testin ...... rse effects, and costs of care
@ast
Gene expression profile testin ...... rse effects, and costs of care
@en
prefLabel
Gene expression profile testin ...... rse effects, and costs of care
@ast
Gene expression profile testin ...... rse effects, and costs of care
@en
P2093
P2860
P1476
Gene expression profile testin ...... rse effects, and costs of care
@en
P2093
Elena B Elkin
Kathryn A Phillips
Michael J Hassett
Stephen Shiboski
Su-Ying Liang
P2860
P2888
P304
P356
10.1007/S10549-011-1628-6
P407
P577
2011-06-17T00:00:00Z